Research Opportunities
New Scleroderma Trails
We have several new scleroderma trials! Several exciting early trials using anti – TGFbeta monoclonal agents for scleroderma (diffuse skin up to 10 years in duration) as well as several phase 3 trials looking an anifrolumab (interferon antagonist) in diffuse scleroderma. We also have new trials for ILD, including an exciting molecule that hopes to affect both skin and lung. Please reach out to the contacts below if you have any questions.
Thanks so much for always supporting clinical trials in scleroderma!
Virgina Steen, MD
steenv@georgetown.edu
Peyton Murray
Research Coordinator
pm1141@georgetown.edu
Opportunity for Physicians to Participate in Lupus Research Program with NMQF
The National Minority Quality Forum (NMQF) invites community-serving rheumatologists and lupus specialists in Washington, DC, Maryland, and Virginia to apply for a unique grant-funded program from the Department of Health and Human Services Office of Minority Health (HHS OMH). This initiative is designed to increase minority participation in lupus clinical trials by training community clinicians as Principal Investigators (PIs).
Participating physicians will receive comprehensive training in clinical research best practices, along with financial and logistical support to reduce the demands of research. By equipping underrepresented community clinicians with essential resources, we aim to expand diverse participation in lupus trials and improve community access to these vital studies.
Join us in empowering communities and enhancing lupus research.
To learn more, please reach out to Christina Edwards, MHA cedwards@nmqf.org
Contact Us.
"*" indicates required fields